Development and maturation of invariant NKT cells in the presence of lysosomal engulfment

European Journal of Immunology

Volumn 39, Issue 10, 2009, Pages 2748-2754

  Plati, Tiziana ^a   Visigalli, Ilaria ^a   Capotondo, Alessia ^a,b   Buono, Mario ^c   Naldini, Luigi ^a,b   Cosma, Maria Pia ^c   Biffi, Alessandra ^a  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

Author keywords

Invariant NKT cells; Lysosomal storage disorders; Selecting ligand

Indexed keywords

GLYCOSAMINOGLYCAN; GLYCOSPHINGOLIPID; SULFATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELL SELECTION; CONTROLLED STUDY; ENZYME DEFICIENCY; INVARIANT NATURAL KILLER T CELL; LYMPHOCYTOPOIESIS; LYSOSOME STORAGE DISEASE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; CELL COUNT; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; LEUKODYSTROPHY, GLOBOID CELL; LEUKODYSTROPHY, METACHROMATIC; LIVER; LYMPHOCYTES; LYSOSOMAL STORAGE DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUCOPOLYSACCHARIDOSIS I; MULTIPLE SULFATASE DEFICIENCY DISEASE; NATURAL KILLER T-CELLS; PYRROLES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SANDHOFF DISEASE; SPLEEN; THYMUS GLAND;

EID: 70350553839     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939639     Document Type: Article

References (21)

1. Chiu, Y. H., Park, S. H., Benlagha, K., Forestier, C., Jayawardena-Wolf, J., Savage, P. B., Teyton, L. and Bendelac, A., Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat. Immunol. 2002. 3: 55-60.
2. Honey, K., Benlagha, K., Beers, C., Forbush, K., Teyton, L., Kleijmeer, M. J., Rudensky, A. Y. and Bendelac, A., Thymocyte expression of cathepsin L is essential for NKT cell development. Nat. Immunol. 2002. 3: 1067-1074.
3. Zhou, D., Mattner, J., Cantu, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y. et al., Lysosomal glycosphingolipid recognition by NKT cells. Science 2004. 306: 1786-1789. (Pubitemid 39601398)
4. Naidenko, O. V., Maher, J. K., Ernst, W. A., Sakai, T., Modlin, R. L. and Kronenberg, M., Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J. Exp. Med. 1999. 190: 1069-1080.
5. Stanic, A. K., De Silva, A. D., Park, J. J., Sriram, V., Ichikawa, S., Hirabyashi, Y., Hayakawa, K. et al., Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency. Proc. Natl. Acad. Sci. USA 2003. 100: 1849-1854.
6. Godfrey, D. I. and Berzins, S. P., Control points in NKT-cell development. Nat. Rev. Immunol. 2007. 7: 505-518.
7. Porubsky, S., Speak, A. O., Luckow, B., Cerundolo, V., Platt, F. M. and Gröne, H. J., Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. USA 2007. 104: 5977-5982.
8. Speak, A. O., Salio, M., Neville, D. C., Fontaine, J., Priestman, D. A., Platt, N., Heare, T. et al., Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA 2007. 104: 5971-5976.
9. Gadola, S. D., Silk, J. D., Jeans, A., Illarionov, P. A., Salio, M., Besra, G. S., Dwek, R. et al., Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 2006. 203: 2293-2303.
10. Schümann, J., Facciotti, F., Panza, L., Michieletti, M., Compostella, F., Collmann, A., Mori, L. and De Libero, G., Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. Eur. J. Immunol. 2007. 37: 1431-1441.
11. Gieselmann, V., Polten, A., Kreysing, J., Kappler, J., Fluharty, A. and von Figura, K., Molecular genetics of metachromatic leukodystrophy. Dev. Neurosci. 1991. 13: 222-227.
12. Hess, B., Saftig, P., Hartmann, D., Coenen, R., Lullmann-Rauch, R., Goebel, H. H., Evers, M. et al., Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc. Natl. Acad. Sci. USA 1996. 93: 14821-14826.
13. Suzuki, K., Globoid cell leukodystrophy (Krabbe's disease): update. J. Child Neurol. 2003. 18: 595-603. (Pubitemid 37258464)
14. Suzuki, K. and Suzuki, K., The twitcher mouse: a model for Krabbe disease and for experimental therapies. Brain Pathol. 1995. 5: 249-258.
15. Scott, H. S., Bunge, S., Gal, A., Clarke, L. A., Morris, C. P. and Hopwood, J. J., Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. Hum. Mutat. 1995. 6: 288-302.
16. Cosma, M. P., Pepe, S., Annunziata, I., Newbold, R. F., Grompe, M., Parenti, G. and Ballabio, A., The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Cell 2003. 113: 445-456. (Pubitemid 36588748)
17. Dierks, T., Schmidt, B., Borissenko, L. V., Peng, J., Preusser, A., Mariappan, M. and von Figura, K., Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme. Cell 2003. 113: 435-444. (Pubitemid 36588747)
18. Sardiello, M., Annunziata, I., Roma, G. and Ballabio, A., Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship. Hum. Mol. Genet. 2005. 14: 3203-3217.
19. Settembre, C., Annunziata, I., Spampanato, C., Zarcone, D., Cobellis, G., Nusco, E., Zito, E. et al., Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency. Proc. Natl. Acad. Sci. USA 2007. 104: 4506-4511.
20. Galbiati, F., Basso, V., Cantuti, L., Givogri, M. I., Lopez-Rosas, A., Perez, N., Vasu, C. et al., Autonomic denervation of lymphoid organs leads to epigenetic immune atrophy in a mouse model of Krabbe disease. J. Neurosci. 2007. 27: 13730-13738. (Pubitemid 350278274)
21. Balreira, A., Lacerda, L., Miranda, C. S. and Arosa, F. A., Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model. Br. J. Haematol. 2005. 129: 667-676.